a phase ii study on safety and efficacy of high-dose n-acetylcysteine in patients with cystic fibrosis第二阶段研究安全性和有效性的囊性纤维化患者大剂量防治作用.pdfVIP

a phase ii study on safety and efficacy of high-dose n-acetylcysteine in patients with cystic fibrosis第二阶段研究安全性和有效性的囊性纤维化患者大剂量防治作用.pdf

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
a phase ii study on safety and efficacy of high-dose n-acetylcysteine in patients with cystic fibrosis第二阶段研究安全性和有效性的囊性纤维化患者大剂量防治作用

352 EUROPEAN J OURNAL OF MEDICAL RESEARCH August 12, 2009 Eur J Med Res (2009) 14: 352-358 © I. Holzapfel Publishers 2009 A PHASE II STUDY ON SAFETY AND EFFICACY OF HI H-DOSE N-ACETYLCYSTEINE IN PATIENTS WITH CYSTIC FIBROSIS 1 1 1 2 3 2 1 N. Dauletbaev , P. Fischer , B. Aulbach , J. ross , W. Kusche , U. Thyroff-Friesinger , T. O. F. Wagner , J. Bargon 1, 4 1University Hospital, Frankfurt/Main, 2Hexal A , Holzkirchen, 3A.CRO Clinical Research Services GmbH, Wiesbaden, 4Hospital St. Elisabeth, Frankfurt/Main, ermany Abstract fore, antioxidant drugs may be useful to control both Obje ctive: We conducted a single-centre, randomised, oxidative stress and excessive inflammation in CF air- double-blinded, placebo-controlled phase II clinical ways. study to test safety and efficacy of a 12-week therapy While the safety and clinical efficacy of corticos- with low-dose (700 mg/daily) or high-dose (2800 teroids and high-dose ibuprofen have been thoroughly mg/daily) of NAC. tested in clinical studies, NAC has not been studied as M ethods: Twenty-one patients (∆F508 homo/hetero- extensively. To date, only one short-term, open, un- zygous, FEV1 40% pred.) were included in the controlled, phase I study on NAC in CF has been pub- study. Afte

您可能关注的文档

文档评论(0)

118zhuanqian + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档